Leavell Investment Management Inc. Increases Position in Cardinal Health, Inc. $CAH

Leavell Investment Management Inc. lifted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 7.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,312 shares of the company’s stock after buying an additional 851 shares during the quarter. Leavell Investment Management Inc.’s holdings in Cardinal Health were worth $2,068,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of CAH. JPMorgan Chase & Co. grew its position in shares of Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after buying an additional 1,193,983 shares in the last quarter. Northern Trust Corp increased its position in Cardinal Health by 3.5% during the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock valued at $433,012,000 after purchasing an additional 105,154 shares during the period. Wellington Management Group LLP lifted its position in shares of Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after purchasing an additional 2,249,241 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of Cardinal Health by 3.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company’s stock valued at $227,877,000 after purchasing an additional 52,714 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in Cardinal Health by 0.6% during the first quarter. Dimensional Fund Advisors LP now owns 1,246,788 shares of the company’s stock valued at $171,749,000 after buying an additional 7,940 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH opened at $161.83 on Friday. The company’s fifty day moving average price is $152.75 and its 200-day moving average price is $152.88. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44. The firm has a market capitalization of $38.45 billion, a PE ratio of 25.09, a price-to-earnings-growth ratio of 1.37 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm’s revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.3%. The ex-dividend date was Wednesday, October 1st. Cardinal Health’s dividend payout ratio is 31.63%.

Insider Activity at Cardinal Health

In other Cardinal Health news, CEO Jason M. Hollar sold 107,705 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the completion of the sale, the chief executive officer directly owned 235,901 shares in the company, valued at approximately $35,125,658.90. The trade was a 31.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer owned 26,085 shares in the company, valued at $3,881,969.70. The trade was a 61.45% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 in the last ninety days. 0.12% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

CAH has been the topic of several recent research reports. UBS Group reaffirmed a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research report on Tuesday, August 12th. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. Morgan Stanley reaffirmed an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Robert W. Baird upped their price target on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 13th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.